scholarly article | Q13442814 |
P356 | DOI | 10.1002/JNR.1093 |
P698 | PubMed publication ID | 11340649 |
P2093 | author name string | O García | |
L Massieu | |||
P2860 | cites work | Inhibition of glutamate uptake induces progressive accumulation of extracellular glutamate and neuronal damage in rat cortical cultures | Q71507107 |
Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism | Q71655959 | ||
Exacerbation of NMDA, AMPA, and L-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate | Q71689201 | ||
Resuscitation of brain neurons in the presence of Ca2+ after toxic NMDA-receptor activity | Q71702080 | ||
Properties of AMPA receptors expressed in rat cerebellar granule cell cultures: Ca2+ influx studies | Q71706004 | ||
Selective neurotoxicity of ruthenium red in primary cultures | Q71706146 | ||
NMDA Receptor Activation Produces Concurrent Generation of Nitric Oxide and Reactive Oxygen Species: Implications for Cell Death | Q71832406 | ||
Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: an in vivo microdialysis study | Q72169616 | ||
Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum | Q72901520 | ||
3-Nitropropionic acid: an astrocyte-sparing neurotoxin in vitro | Q73342059 | ||
Oxidative stress during energy impairment in mesencephalic cultures is not a downstream consequence of a secondary excitotoxicity | Q73466814 | ||
Neuroprotective effects of creatine administration against NMDA and malonate toxicity | Q73571747 | ||
In vivo potentiation of glutamate-mediated neuronal damage after chronic administration of the glycolysis inhibitor iodoacetate | Q74332185 | ||
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism. | Q30978603 | ||
Mitochondria in neurodegeneration: bioenergetic function in cell life and death | Q33541512 | ||
Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function | Q34296896 | ||
3-Acetylpyridine produces age-dependent excitotoxic lesions in rat striatum. | Q36723864 | ||
D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease | Q36976707 | ||
ATP and brain function | Q38597443 | ||
Excitatory amino acid-induced alterations of cytoplasmic free Ca2+ in individual cerebellar granule neurons: role in neurotoxicity | Q39243523 | ||
3-Nitropropionic acid exacerbates N-methyl-D-aspartate toxicity in striatal culture by multiple mechanisms. | Q39449440 | ||
The role of neuronal energy in the neurotoxicity of excitatory amino acids | Q39523207 | ||
Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced | Q39531608 | ||
Evidence that the loss of the voltage-dependent Mg2+ block at the N-methyl-D-aspartate receptor underlies receptor activation during inhibition of neuronal metabolism | Q41096804 | ||
Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction | Q41549753 | ||
K(+)-induced reversal of astrocyte glutamate uptake is limited by compensatory changes in intracellular Na+. | Q41682921 | ||
Excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by the mitochondrial toxin, 3-nitropropionic acid | Q41711372 | ||
Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. | Q46066087 | ||
Conformationally defined neurotransmitter analogs. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer | Q46602656 | ||
Pyruvate and lactate protect striatal neurons against N-methyl-D-aspartate-induced neurotoxicity | Q48098641 | ||
Ions and energy in mammalian brain | Q48133714 | ||
Effects of lactate and pyruvate on glucose deprivation in rat hippocampal slices. | Q48187773 | ||
NMDA-dependent superoxide production and neurotoxicity | Q48234286 | ||
Transient inhibition of glutamate uptake in vivo induces neurodegeneration when energy metabolism is impaired | Q48307959 | ||
Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity. | Q48340892 | ||
Metabolic control of kynurenic acid formation in the rat brain | Q48371421 | ||
Ketone bodies and brain glutamate and GABA metabolism | Q48371462 | ||
Interference with cellular energy metabolism reduces kynurenic acid formation in rat brain slices: reversal by lactate and pyruvate | Q48387377 | ||
Metabolic inhibition potentiates AMPA-induced Ca2+ fluxes and neurotoxicity in rat cerebellar granule cells | Q48528691 | ||
Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis | Q48609930 | ||
Glutamate Neurotoxicity Is Independent of Calpain I Inhibition in Primary Cultures of Cerebellar Granule Cells | Q48651242 | ||
Ion homeostasis in brain cells: differences in intracellular ion responses to energy limitation between cultured neurons and glial cells | Q48720755 | ||
The glutamate transport inhibitor L-trans-pyrrolidine-2,4-dicarboxylate indirectly evokes NMDA receptor mediated neurotoxicity in rat cortical cultures | Q48923863 | ||
2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia | Q49105194 | ||
The competitive transport inhibitor L-trans-pyrrolidine-2, 4-dicarboxylate triggers excitotoxicity in rat cortical neuron-astrocyte co-cultures via glutamate release rather than uptake inhibition. | Q51562635 | ||
Glutamate release in severe brain ischaemia is mainly by reversed uptake. | Q51977738 | ||
AMPA neurotoxicity in cultured cerebellar granule neurons: mode of cell death. | Q53995482 | ||
Protective Effect of the Energy Precursor Creatine Against Toxicity of Glutamate and β-Amyloid in Rat Hippocampal Neurons | Q58829455 | ||
Lactate-Supported Synaptic Function in the Rat Hippocampal Slice Preparation | Q68381532 | ||
Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases | Q71201898 | ||
P433 | issue | 4 | |
P304 | page(s) | 418-428 | |
P577 | publication date | 2001-05-01 | |
P1433 | published in | Journal of Neuroscience Research | Q6295654 |
P1476 | title | Strategies for neuroprotection against L-trans-2,4-pyrrolidine dicarboxylate-induced neuronal damage during energy impairment in vitro | |
P478 | volume | 64 |
Q44532198 | Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition. |
Q46873531 | Antioxidant activity, cellular bioavailability, and iron and calcium management of neuroprotective and nonneuroprotective flavones |
Q48290603 | Cerebellar granule neurons are more vulnerable to transient transport-mediated glutamate release than to glutamate uptake blockade. correlation with excitatory amino acids levels. |
Q48364448 | D-beta-hydroxybutyrate prevents glutamate-mediated lipoperoxidation and neuronal damage elicited during glycolysis inhibition in vivo |
Q43942172 | Effects of L-glutamate transport inhibition by a conformationally restricted glutamate analogue (2S,1'S,2'R)-2-(carboxycyclopropyl)glycine (L-CCG III) on metabolism in brain tissue in vitro analysed by NMR spectroscopy |
Q44675700 | Glutamate uptake inhibitor L-trans-pyrrolidine 2,4-dicarboxylate becomes neurotoxic in the presence of subthreshold concentrations of mitochondrial toxin 3-nitropropionate: involvement of mitochondrial reducing activity and ATP production |
Q44327958 | Influence of serum-free medium on the expression of glutamate transporters and the susceptibility to glutamate toxicity in cultured cortical neurons. |
Q34971377 | Ketogenic diets: evidence for short- and long-term efficacy |
Q37590056 | Maturation-dependent behavioral deficits and cell injury in developing animals during the subacute postictal period |
Q43832585 | N-Acetyl-L-aspartyl-L-glutamate changes functional and structural properties of rat blood-brain barrier |
Q24646914 | Neuroprotective and disease-modifying effects of the ketogenic diet |
Q43780991 | Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates |
Q34464744 | Pyruvate carboxylation in neurons |
Q48547164 | Veratridine, but not elevated K+, inhibits excitatory amino acid transporter activity in rat hippocampal slices. |
Search more.